Gokhan Yahioglu

Company: Antikor

Job title: Co-Founder & Director R&D Medicinal Chemistry

Seminars:

Uncharted Waters – Overcoming Challenges in Implementing a Novel Conjugate Format 9:00 am

In the ever-evolving landscape of novel drug-conjugates, the pursuit of innovation often leads to unexplored territories. This workshop is designed for industry pioneers who dare to venture where no company has tread before. Offering an immersive exploration into the challenges that accompany the development of groundbreaking conjugates, join us to gain an understanding of the…Read more

day: Pre-Conference Workshop Day

Engineering Antibody Fragments for Enhanced Drug Load & Functionality: The Story of ANT-045, A cMET Targeting FDC 11:00 am

Explore the unique design features of Antikor’s Fragment-Drug Conjugates (FDCs) and learn about our FDC discovery platform, navigating the complexities of conjugating multiple payloads onto smaller antibody fragments, highlighting the importance of an optimised payload-linker Delve into the discovery of Antikor’s lead FDC program (ANT-045) and how we have mitigated aggregation and optimised key properties…Read more

day: Conference Day 2